[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  PharmaShots - Incisive news in X shots [@Pharmashot](/creator/twitter/Pharmashot) on x 2262 followers Created: 2025-07-18 11:41:35 UTC Daiichi Sankyo Reports the US FDA’s Breakthrough Therapy Designation for Enhertu + Perjeta to Treat HER2+ Breast Cancer #daiichisankyo #enhertu #piii #destinybreast09 #pertuzumab #trastuzumab #breastcancer #regulatory  XX engagements  **Related Topics** [breakthrough](/topic/breakthrough) [$6417t](/topic/$6417t) [$4568t](/topic/$4568t) [$8750t](/topic/$8750t) [Post Link](https://x.com/Pharmashot/status/1946173500890214602)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PharmaShots - Incisive news in X shots @Pharmashot on x 2262 followers
Created: 2025-07-18 11:41:35 UTC
Daiichi Sankyo Reports the US FDA’s Breakthrough Therapy Designation for Enhertu + Perjeta to Treat HER2+ Breast Cancer #daiichisankyo #enhertu #piii #destinybreast09 #pertuzumab #trastuzumab #breastcancer #regulatory
XX engagements
Related Topics breakthrough $6417t $4568t $8750t
/post/tweet::1946173500890214602